Literature DB >> 10620070

Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures.

A Teti1, S Migliaccio, A Taranta, S Bernardini, G De Rossi, M Luciani, M Iacobini, L De Felice, R Boldrini, C Bosman, A Corsi, P Bianco.   

Abstract

Osteoclasts from a patient affected by osteopetrosis were examined in vivo and in vitro. Iliac crest biopsy revealed an osteosclerotic pattern, with prominent numbers of osteoclasts noted for hypernuclearity and incomplete adherence to the bone surface. A population comprising tartrate-resistant acid phosphatase (TRAP)-positive, multinucleated and mononuclear cells, and alkaline phosphatase-positive stromal fibroblasts was obtained in vitro from bone marrow. Mononuclear TRAP-positive precursors spontaneously fused in culture to form giant osteoclast-like cells. These cells expressed the osteoclast marker MMP-9 and calcitonin receptor, and lacked the macrophage marker, Fc receptor. Expression and distribution of c-src, c-fms, and CD68, and response to steroid hormones relevant to osteoclast differentiation and function were apparently normal, whereas cell retraction in response to calcitonin was impaired. TRAP-positive multinucleated cells did not form osteoclast-specific adhesion structures (clear zone, podosomes, or actin rings). Bone resorption rate was severely reduced in vitro. Focal adhesions and stress fibers were observed en lieu of podosomes and actin rings. Adhesion structures contained low levels of immunoreactive vitronectin receptor, most of this integrin being retained in cytoplasmic vesicles. These data provide the first characterization of abnormal differentiation and function of human osteopetrotic osteoclast-like cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10620070     DOI: 10.1359/jbmr.1999.14.12.2107

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.

Authors:  Xuehui Yang; Shivangi Pande; Cameron Scott; Robert Friesel
Journal:  J Cell Biochem       Date:  2019-02-25       Impact factor: 4.429

2.  Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data.

Authors:  Brendan Boyce; Lianping Xing
Journal:  Clin Investig (Lond)       Date:  2011-12-01

Review 3.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

4.  A method for whole protein isolation from human cranial bone.

Authors:  Sarah M Lyon; Anoop Mayampurath; M Rose Rogers; Donald J Wolfgeher; Sean M Fisher; Samuel L Volchenboum; Tong-Chuan He; Russell R Reid
Journal:  Anal Biochem       Date:  2016-09-25       Impact factor: 3.365

5.  High bone mass in the STR/ort mouse results from increased bone formation and impaired bone resorption and is associated with extramedullary hematopoiesis.

Authors:  Juliane Pasold; Robby Engelmann; Johannes Keller; Sarah Joost; Robert P Marshall; Bernhard Frerich; Brigitte Müller-Hilke
Journal:  J Bone Miner Metab       Date:  2012-11-29       Impact factor: 2.626

6.  Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

Authors:  A Del Fattore; B Peruzzi; N Rucci; I Recchia; A Cappariello; M Longo; D Fortunati; P Ballanti; M Iacobini; M Luciani; R Devito; R Pinto; M Caniglia; E Lanino; C Messina; S Cesaro; C Letizia; G Bianchini; H Fryssira; P Grabowski; N Shaw; N Bishop; D Hughes; R P Kapur; H K Datta; A Taranta; R Fornari; S Migliaccio; A Teti
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

Review 7.  Molecular regulation of osteoclast activity.

Authors:  Angela Bruzzaniti; Roland Baron
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

8.  Regulation of osteoarthritis by omega-3 (n-3) polyunsaturated fatty acids in a naturally occurring model of disease.

Authors:  L Knott; N C Avery; A P Hollander; J F Tarlton
Journal:  Osteoarthritis Cartilage       Date:  2011-07-01       Impact factor: 6.576

9.  The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly.

Authors:  Chen Luxenburg; Dafna Geblinger; Eugenia Klein; Karen Anderson; Dorit Hanein; Benny Geiger; Lia Addadi
Journal:  PLoS One       Date:  2007-01-31       Impact factor: 3.240

10.  Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis.

Authors:  Anna Taranta; Silvia Migliaccio; Irene Recchia; Maurizio Caniglia; Matteo Luciani; Giulio De Rossi; Carlo Dionisi-Vici; Rita M Pinto; Paola Francalanci; Renata Boldrini; Edoardo Lanino; Giorgio Dini; Giuseppe Morreale; Stuart H Ralston; Anna Villa; Paolo Vezzoni; Domenico Del Principe; Flaminia Cassiani; Giuseppe Palumbo; Anna Teti
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.